NCI-Navy Medical Oncology Branch cell line data base

Journal of Cellular Biochemistry

Volumn 62, Issue SUPPL. 24, 1996, Pages 32-91

  Phelps, Ruby M ^a   Johnson, Bruce E ^a   Ihde, Daniel C ^a   Gazdar, Adi F ^a   Carbone, David P ^a   McClintock, Patrick R ^b   Linnoila, R Ilona ^a   Matthews, Mary J ^a   Bunn Jr , Paul A ^a   Carney, Desmond ^a   Minna, John D ^a   Mulshine, James L ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b AMERICAN TYPE CULTURE COLLECTION   (United States)

Author keywords

cell lines; clinical correlation; in vitro data; lung cancer; polymorphic markers

Indexed keywords

ANALYTIC METHOD; ARTICLE; CELL LINE; DATA ANALYSIS; DATA BASE; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG CANCER; LYMPHOBLASTOID CELL; ONCOLOGY; PRIORITY JOURNAL; CELL CULTURE; COMPUTER NETWORK; FACTUAL DATABASE; HEALTH CARE FACILITY; HEALTH CARE ORGANIZATION; LUNG TUMOR; MILITARY MEDICINE; NEOPLASM; ORGANIZATION AND MANAGEMENT; PATHOLOGY; UNITED STATES;

BIOLOGICAL SPECIMEN BANKS; COMPUTER COMMUNICATION NETWORKS; DATABASES, FACTUAL; HUMANS; LUNG NEOPLASMS; MARYLAND; MEDICAL ONCOLOGY; MILITARY MEDICINE; NATIONAL INSTITUTES OF HEALTH (U.S.); NEOPLASMS; TUMOR CELLS, CULTURED; UNITED STATES;

EID: 33646953271     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.240630505     Document Type: Article

References (16)

1. Gazdar A, Helman L, Israel M, et al (1988): Expression of neuroendocrine cell markers L-dopa decarboxylase, chromogranin A, and dense core granules in human tumors of endocrine and nonendocrine origin. Cancer Res 48:4078-4082.
2. Brower M, Carney D, Oie H, et al (1986): Growth of cell lines and clinical specimens of human non-small cell lung cancer in a serum-free defined medium. Cancer Res 46:798-806.
3. Gazdar A, Oie H (1986): Correspondence regarding growth of cell lines and clinical specimens of human non-small cell lung lung cancer in a serum free defined medium [letter]. Cancer Res 46:6011.
4. Simms E, Gazdar A, Abrams P, Minna J (1980): Growth of human small cell (oat cell) carcinoma of the lung in serum-free growth factor-supplemented medium. Cancer Res 40:4356-4363.
5. Cohen M, Ihde D, Bunn P, et al (1979): Cyclic alternating combination chemotherapy for small cell bronchogenic carcinoma. Cancer Treat Rep 63:163-170.
6. Doyle L, Ihde D, Carney D, Bunn P (1984): Combination chemotherapy with doxorubicin and mitomycin C in non-small cell bronchogenic carcinoma. Severe pulmonary toxicity from q 3 weekly mitomycin C. Am J Clin Oncol 7:719-724.
7. Brower M, Ihde D, Johnston-Early A, Bunn P, et al (1983): Treatment of extensive stage small cell bronchogenic carcinoma. Effects of variation in intensity of induction chemotherapy. Am J Med 75:993-1000.
8. Ihde D, Deisseroth A, Lichter A, et al (1986): Late intensive combined modality therapy followed by autologous bone marrow infusion in extensive-stage small-cell lung cancer. J Clin Oncol 4:1443-1454.
9. Bunn P, Lichter A, Makuch R, et al (1987): Chemotherapy alone or chemotherapy with chest radiation therapy in limited stage small cell lung cancer: A prospective randomized trial. Ann Intern Med 106:655-662.
10. Stevenson H, Gazdar A, Phelps R, et al (1990): Tumor cell lines established in vitro: An independent prognostic factor for survival in non-small cell lung cancer. Ann Intern Med 113:764-770.
11. Shaw G, Gazdar A, Phelps R, et al (1994): Individualized chemotherapy for patients with non-small cell lung cancer determined by prospective identification of neuroendocrine markers and in vitro drug sensitivity testing. Cancer Res 53:5181-5187
12. Ihde D, Mulshine J, Kramer B, et al (1994): Randomized comparison of high-dose and standard-dose etoposide (VP16.) and cisplatin in patients with disseminated small cell lung cancer (SCLC). J Clin Oncol 12:2022-2034.
13. Dmitrovsky E, Seifter E, Gazdar A, Tsai C, et al (1990): A phase II trial of carboplatin (CBDCA) in small-cell and non-small cell lung cancer with correlation to in vitro analysis of cytotoxicity. Am J Clin Oncol 13:285-289
14. Johnson B, Parker R, Strong J, Tsai C, et al (1990): Completion of the dihydrolenperone (DHLP) phase 1 trial. A novel compound with in vitro activity against lung cancer. Proc Am Soc Clin Oncol 9:230.
15. Mulshine J, Avis I, Carrasquillo J, et al (1990): Phase 1 study of an anti gastrin releasing peptide (GRP) monoclonal antibody in patients with lung cancer. Proc Am Soc Clin Oncol 9:230.
16. Johnson B, Salem C, Nesbitt J, et al (1991): Limited (LTD) stage small cell lung cancer (SCLC) treated with concurrent BID chest radiotherapy (RT) and etoposide/ cisplatin (VP/PL) followed by chemotherapy (CT) selected by in vitro drug sensitivity testing (DST). Proc Am Soc Clin Oncol 10:240, 1991.